U
Nirvana Life Sciences Inc. NIRVF
$0.0083 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

10/31/2024 07/31/2024 04/30/2024 01/31/2024 10/31/2023
Net Income -337.90K -417.20K -646.90K -910.50K -1.09M
Total Depreciation and Amortization 13.50K 13.50K 13.50K 25.90K 33.90K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 46.90K 60.40K 228.20K 612.80K 721.40K
Change in Net Operating Assets 245.10K 280.00K 264.00K 84.10K 133.10K
Cash from Operations -32.40K -63.30K -141.30K -187.70K -199.80K
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued 49.50K 25.50K 28.20K -9.50K 11.90K
Total Debt Repaid 50.00K 50.00K 0.00 -50.00K -50.00K
Issuance of Common Stock 0.00 25.00K 210.10K 320.00K 320.00K
Repurchase of Common Stock -59.10K -59.10K -59.10K -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 9.10K 9.10K 0.00 -9.10K -9.10K
Cash from Financing 36.30K 37.10K 133.80K 187.20K 203.00K
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -11.30K -2.20K -- -- --
Net Change in Cash -7.40K -28.30K -7.40K -400.00 3.30K
Weiss Ratings